OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $122,294 | -36.9% | 38,947 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $193,825 | -1.1% | 37,563 | +1.0% | 0.00% | 0.0% |
| Q1 2023 | $195,986 | +91.4% | 37,189 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $102,422 | -32.6% | 36,449 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $152,000 | +4.8% | 36,582 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $145,000 | -22.9% | 36,065 | -5.2% | 0.00% | 0.0% |
| Q1 2022 | $188,000 | -33.8% | 38,058 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $284,000 | -32.4% | 40,737 | -2.9% | 0.00% | -50.0% |
| Q3 2021 | $420,000 | -31.0% | 41,955 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $609,000 | -12.6% | 42,952 | +1.1% | 0.00% | 0.0% |
| Q1 2021 | $697,000 | -15.5% | 42,479 | +6.5% | 0.00% | -33.3% |
| Q4 2020 | $825,000 | +200.0% | 39,872 | +10.2% | 0.00% | +200.0% |
| Q3 2020 | $275,000 | +5.4% | 36,170 | +15.4% | 0.00% | 0.0% |
| Q2 2020 | $261,000 | +110.5% | 31,355 | +25.4% | 0.00% | 0.0% |
| Q1 2020 | $124,000 | +19.2% | 25,003 | -5.5% | 0.00% | – |
| Q4 2019 | $104,000 | +30.0% | 26,448 | +1.0% | 0.00% | – |
| Q3 2019 | $80,000 | -23.8% | 26,181 | +9.4% | 0.00% | – |
| Q2 2019 | $105,000 | +16.7% | 23,929 | +5.5% | 0.00% | – |
| Q1 2019 | $90,000 | +3.4% | 22,674 | +3.1% | 0.00% | – |
| Q4 2018 | $87,000 | -42.8% | 21,983 | -0.8% | 0.00% | -100.0% |
| Q3 2018 | $152,000 | +7.0% | 22,152 | +5.4% | 0.00% | – |
| Q2 2018 | $142,000 | +18.3% | 21,013 | +14.0% | 0.00% | – |
| Q1 2018 | $120,000 | +76.5% | 18,434 | +21.4% | 0.00% | – |
| Q4 2017 | $68,000 | -26.9% | 15,185 | +0.5% | 0.00% | – |
| Q3 2017 | $93,000 | -28.5% | 15,115 | +8.1% | 0.00% | – |
| Q2 2017 | $130,000 | +26.2% | 13,985 | +25.6% | 0.00% | – |
| Q1 2017 | $103,000 | +19.8% | 11,138 | +8.2% | 0.00% | – |
| Q4 2016 | $86,000 | -99.9% | 10,294 | -0.3% | 0.00% | – |
| Q3 2016 | $70,905,000 | +39.0% | 10,321 | +0.1% | 0.00% | – |
| Q2 2016 | $51,015,000 | -31.1% | 10,306 | +35.0% | 0.00% | – |
| Q1 2016 | $74,000,000 | +2.8% | 7,632 | 0.0% | 0.00% | – |
| Q4 2015 | $72,000,000 | +66566.7% | 7,632 | -0.2% | 0.00% | – |
| Q3 2015 | $108,000 | -99.9% | 7,646 | +0.1% | 0.00% | -100.0% |
| Q2 2015 | $160,606,000 | +5.8% | 7,637 | +111.3% | 0.00% | 0.0% |
| Q1 2015 | $151,776,000 | +78.5% | 3,615 | 0.0% | 0.00% | – |
| Q4 2014 | $85,025,000 | – | 3,615 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |